To include your compound in the COVID-19 Resource Center, submit it here.

CLBS03: Ph II ongoing

An independent DSMB recommended continuation to the second cohort of the double-blind,

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE